Arkolith/Insider Trading/ETTX/Form 4

Keiley Elizabeth M

General CounselEntasis Therapeutics Holdings Inc. (ETTX) · full profile →Form 4 · filed Feb 15, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 16, 2021Grant(A)21K——21K
Jul 16, 2021Disposed to issuer(D)25K——0

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-023766) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML